LENZ Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
LENZ Therapeutics Depreciation & Amortization Growth & History (LENZ)
LENZ Therapeutics's depreciation and amortization was $287,000 for fiscal 2025.
View full LENZ Therapeutics company overviewLENZ Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $287,000 | $229,000 | +394.83% |
| 2024 | 2024-12-31 | $58,000 | $43,000 | +286.67% |
| 2023 | 2023-12-31 | $15,000 | −$2.3M | −99.36% |
| 2022 | 2022-12-31 | $2.4M | $1.6M | +220.44% |
| 2021 | 2021-12-31 | $734,000 | $613,000 | +506.61% |
| 2020 | 2020-12-31 | $121,000 | — | — |
LENZ Therapeutics quarterly depreciation and amortization
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $110,000 | $91,000 | +478.95% |
| Q1 2026 | 2026-03-31 | $111,000 | $75,000 | +208.33% |
| Q4 2025 | 2025-12-31 | $107,000 | — | — |
| Q3 2025 | 2025-09-30 | $125,000 | $115,000 | +1150.00% |
| Q2 2025 | 2025-06-30 | $19,000 | $1,000 | +5.56% |
| Q1 2025 | 2025-03-31 | $36,000 | $31,000 | +620.00% |
| Q3 2024 | 2024-09-30 | $10,000 | $6,000 | +150.00% |
| Q2 2024 | 2024-06-30 | $18,000 | $14,000 | +350.00% |
| Q1 2024 | 2024-03-31 | $5,000 | $2,000 | +66.67% |
| Q3 2023 | 2023-09-30 | $4,000 | −$648,000 | −99.39% |
| Q2 2023 | 2023-06-30 | $4,000 | −$574,000 | −99.31% |
| Q1 2023 | 2023-03-31 | $3,000 | −$437,000 | −99.32% |
| Q3 2022 | 2022-09-30 | $652,000 | $454,000 | +229.29% |
| Q2 2022 | 2022-06-30 | $578,000 | $462,000 | +398.28% |
| Q1 2022 | 2022-03-31 | $440,000 | $350,000 | +388.89% |
| Q3 2021 | 2021-09-30 | $198,000 | $198,000 | — |
| Q2 2021 | 2021-06-30 | $116,000 | $115,000 | +11500.00% |
| Q1 2021 | 2021-03-31 | $90,000 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $1,000 | — | — |
LENZ Therapeutics depreciation and amortization trends
Over the last five fiscal years, LENZ Therapeutics's depreciation and amortization increased from $121,000 to $287,000, a change of $166,000. The latest reported quarter, Q2 2026, shows $110,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LENZ Therapeutics source filings ↗